Postural Management of Hyperkyphosis to Improve Motor Performance and Pulmonary Function in Cardiac Rehabilitation Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 2
- 主要终点
- Degree of Kyphosis
研究概览
简要总结
The goal of this clinical trial is to evaluate the efficacy of a home-based exercise program in managing hyperkyphosis, and its impact on physical performance and pulmonary function among cardiac rehabilitation patients.
The primary research question is: Can a home-based kyphosis-specific exercise program reduce thoracic hyperkyphosis and improve physical ability in cardiac patients undergoing cardiac rehabilitation? The study will consist of three groups: 1) Hyperkyphotic participants undergoing a 12-week exercise program at home, alongside a cardiac rehabilitation exercise program, 2) Hyperkyphotic participants solely undergoing cardiac rehabilitation exercise program, and 3) Participants without hyperkyphosis solely undergoing cardiac rehabilitation exercise program.
The groups will be evaluated based on measurements of kyphosis index, physical performance and spirometry at the beginning, after 6 weeks, and upon completion of the 12-week program.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 40 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Heart patients who will be admitted for cardiac rehabilitation at Hadassah - Mount Scopus Hospital
- •Normal stress test results.
- •Independent mobility.
- •Stable hemodynamic and respiratory status.
- •Ability to speak and read basic Hebrewץ
- •Ability to watch videos on a mobile phone or computer.
- •Not receiving any other forms of physical therapy or physical treatment.
排除标准
- •Presence of unstable angina.
- •Neurological disorders or mental illnesses that interfere with communication.
- •Movement disorders due to neurological disease.
- •Severe orthopedic limitations hindering the execution of motor exercises.
结局指标
主要结局
Degree of Kyphosis
时间窗: Assessment will occur at baseline, after 6 weeks, and upon completion of the 12-week program.
This measure will be obtained using a 60-centimeter flexicurve ruler, placed over the subject's back, from the C7 spinous process down to the T12 spinous process. Once attached to the back, the flexicurve molds according to its shape, allowing tracing of the thoracic curve onto paper. Maximum width and length measurements are then taken of the curve in centimeters in order to calculate the kyphosis index. Kyphosis index is calculated as the ratio of thoracic width to thoracic length. A higher index value indicates a greater degree of kyphosis, with values exceeding 13 considered hyperkyphosis. Assessment will occur at the program's start, after 6 weeks, and upon completion of the 12-week program.
次要结局
- Maximum Metabolic Equivalents (METs)(The measurement will be taken at baseline and upon completion of the 12-week program.)
- Peak Heart Rate(The measurement will be taken at baseline and upon completion of the 12-week program.)
- Peak Systolic and Diastolic Blood Pressure(The measurement will be taken at baseline and upon completion of the 12-week program.)
- Time to complete the Five Times Sit to Stand Test (FTSST)(The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.)
- Time to climb one flight of stairs(The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.)
- Timed Up & Go Test (TUG)(The The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.)
- Distance covered in a six-minute walk test(The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.)
- Forced Vital Capacity (FVC)(The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.)
- Forced Expiratory Volume in one second (FEV1)(The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.)
- Adherence to home-based program(From enrollment to the end of treatment at 12 weeks)
- Functional Reach Test (FRT)(The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.)